Lifshitz & Miller has launched investigations on of Argos Therapeutics Inc (NASDAQ:ARGS) investors regarding whether the company exaggerated the potential of its AGS-003 drug to treat metastatic renal cell carcinoma.
Avid Technology, Inc. (NASDAQ:AVID), is also under investigation after the company delayed its conference call of its financial results for the fourth quarter of 2016. HMS Holdings Corp (NASDAQ:HMSY) is under investigation to establish if the company has weaknesses in its operations after it delayed its 2016 annual financial report.
Additionally, Lifshitz & Miller has announced investigations on behalf of investors of Invuity, Inc. (NASDAQ:IVTY) to establish whether Invuity presented accurate data concerning the sustainability of its annual revenue per account. Sito Mobile Ltd (NASDAQ:SITO) is under investigation concerning the accuracy of its revenue growth data due to the 2016 elections and spending on clients’ campaign.
Trevena Inc (NASDAQ:TRVN), is being investigated by Lifshitz & Miller after Trevena announced that the clinical results of Oliceridine, the company’s morphine-alternative drug has low levels of safety and tolerability in comparison to standard morphine. USANA Health Sciences, Inc. (NYSE:USNA) is also being investigated concerning allegations of the company’s subsidiary was involved in practices of improper reimbursement in China
Lifshitz & Miller is investigation VAALCO Energy, Inc. (NYSE:EGY) concerning claims of misstatement in its financial results after the company spotted weaknesses in its internal control mechanisms over the financial reporting.
Air Methods Corp (NASDAQ:AIRM), Fortress Investment Group LLC (NYSE:FIG), Galena Biopharma Inc (NASDAQ:GALE), Ionis Pharmaceuticals Inc (NASDAQ:IONS), LMI Aerospace, Inc. (NASDAQ:LMIA), Lumos Networks Corp (NASDAQ:LMOS), Silver Bay Realty Trust Corp (NYSE:SBY) and TerraForm Global Inc (NASDAQ:GLBL) are also facing separate investigations on a range of issues.
Air Methods Corp is being investigated for possible breach of duties by its board in relation to the proposed sale of the company to American Securities LLC while Fortress Investment Group is under investigation for possible breach of duties of its board in regards to the sale of the company to Japan’s SoftBank Group Corp at the rate of $8.08 in cash per share.
